In an in vivo trial, triple combination therapy, i.e., radiation combined with PD-L1 monoclonal antibody and anlotinib, was used to improve the tumor microenvironment and to counteract the immunosuppressive effects of radiation on the tumor microenvironment in Lewis lung cancer mice. The gene discussed is CD274; the disease is neoplasm.